The incidence of cough induced by remifentanil during anesthetic induction was decreased by graded escalation of the remifentanil concentration by Lim, Ji Hun et al.
Korean J Anesthesiol 2010 Feb; 58(2): 117-121 
DOI: 10.4097/kjae.2010.58.2.117  Clinical Research Article
Copyright ⓒ Korean Society of Anesthesiologists, 2010 www.ekja.org
Background:  It is well known that opioids induce coughing.  Many drugs such as lidocaine and ketamine are used 
to effectively prevent the coughing induced by opioids and this has been revealed to be effective.  In this study, we 
evaluated the preventive effect of a graded escalation of the remifentanil concentration using a target controlled 
infusion pump and we compared this with the effect of lidocaine.
Methods:  One hundred fifty ASA I and II patients who were scheduled for elective surgery were randomly divided 
into 3 groups.  The patients were pretreated with 2% lidocaine 1 mg/kg (Group L) or saline (Group S) and remifentanil 
infusion (an effect site concentration of 4.0 ng/ml) was followed 1 minute later by using a target controlled infusion 
pump.  Group R was pretreated with saline and this was followed by remifentanil infusion (effect site concentration 
of 2.0 ng/ml at first and then it was reset to 4.0 ng/ml).  We evaluated the incidence, severity and onset time of cough 
after remifentanil infusion.
Results:  The incidence of coughing was significantly decreased in Group R (6 cases, 12%) and Group L (7 cases, 
14%), as compared to that of Group S (17 cases, 34%) (P < 0.05), but there was no significant difference between 
Group R and Group L. The groups showed no significant difference in the severity and the onset time of coughing.
Conclusions: This study demonstrated that administering graded escalation of the remifentanil concentration 
suppresses remifentanil-induced coughing as effectively as lidocaine 1 mg/kg pretreatment.  (Korean J Anesthesiol 
2010; 58: 117-121)
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Introduction 
    Remifentanil has a rapid onset time and a short context-
sensitive half time, so it is useful as an adjuvant for inhalational 
anesthesia and total intravenous anesthesia. It is effective in 
reducing the perioperative hemodynamic, the autonomic 
responses and the somatic responses [1]. Although it was 
known that opioid suppresses the cough reflex during tracheal 
intubation, administrating a small amount of remifentanil was 
reported to cause coughing just like administering fentanyl 
[2]. The incident rate of remifentanil-induced coughing is 
about 27-28% [2,3]. Coughing during anesthetic induction 
can increase the intracranial pressure, the intraocular pressure 
and the intraperitoneal pressure. Continuous coughing may 
sometimes require sedatives or muscle relaxants [4]. Many 
methods are used during anesthetic induction to reduce the 
occurrence of fentanyl-induced and remifentanil-induced 
coughing. The intravenous administration of selective beta-2 
agonists (terbutaline and salbutamol), lidocaine and ketamine 
are known to reduce fentanyl-induced and remifentanil-
induced coughing [2,3,5-8]. Lin et al. [9] reported that the 
prolonged injection time and the slow administration of 
fentanyl decreased the incidence of fentanyl-induced coughing. 
However, there have been no research studies published on the 
effects of a prolonged injection time and the graded escalation 
of remifentanil to reduce remifentanil-induced coughing. 
    The objective of the study was to determine if the graded 
escalation of the remifentanil concentration using a target-
controlled infusion pump is effective for reducing remifentanil-
induced coughing. The effect of a graded escalation of the 
remifentanil concentration was also compared with the effect of 
lidocaine pretreatment.
Materials and Methods
    The subjects were 150 men and women patients between 
the ages of 20 and 60, ASA I and II, and they were undergoing 
an elective operation under general anesthesia. With the 
permission of the local institutional review board, we explained 
to the patients during the preanesthetic visit about the research 
study and we obtained their permission to include them into 
the study. We excluded those patients with bronchial asthma, 
chronic obstructive pulmonary disease, respiratory tract 
infection, hypertension and allergy to local anesthetics, and the 
smokers from the study group. 
    We did not perform anesthetic premedication. Before 
arriving in the operating room, vascular access was secured 
with an 18 G needle in the patient’s forearm, and we started 
fluid administration using lactate Ringer's solution. When the 
patient arrived in the operating room, an electrocardiograph, a 
noninvasive blood pressure manometer and a pulse oximeter 
were placed for monitoring. The patients were randomly 
divided into 3 groups with 50 patients in each group. Group L 
was intravenously injected with 2% lidocaine 1 mg/kg. After 
1 minute, the remifentanil’s effect site concentration was set 
at 4.0 ng/ml using a target controlled infusion pump (TCI, 
[Orchestra
ⓇFresenius Vial, Brezims, France]). In Group S, we 
administered normal saline of the same amount as the 2% 
lidocaine (1 mg/kg). After 1 minute, remifentanil’s effect site 
concentration was set at 4.0 ng/ml with the TCI pump. Group R 
was administered normal saline of the same amount as the 2% 
lidocaine (1 mg/kg). One minute after this, remifentanil’s effect 
site concentration was set at 2.0 ng/ml. When the effect site 
concentration reached 2.0 ng/ml, it was reset at 4.0 ng/ml and 
administered by graded escalation. When the remifentanil’s 
effect site concentration reached 4.0 ng/ml, the propofol’s 
effect site concentration was set at 4.0 ug/ml followed by 
continuous infusion. Loss of consciousness was observed. 
After administering remifentanil, an observer who was not 
informed about the administered drugs recorded the onset 
time of coughing (from the beginning of TCI to the beginning of 
coughing) and the cough severity over the period of 1 minute. 
The cough severity was evaluated by the number of coughs 
(light: 1-2, moderate: 3-4, severe: 5+). During the patient 
observation, 100% oxygen was administered immediately by 
mask when the oxygen saturation fell below 95%. We evaluated 
for any apnea and/or muscle rigidity. Apnea was defined as 
when breathing stopped for more than 15 seconds. Muscle 
rigidity was defined as increased tone of the trunk muscles, 
where ventilation with the face mask was difficult or not 
possible. After remifentanil administration, we administered 
propofol and recorded the incidence of pain. The severity of 
pain was recorded on a scale of 0-3 (pain score 0: negative 
response to question, 1: pain in response to questioning only 
without any behavioral signs, 2: pain in response to questioning 
and accompanied by behavioral signs or pain reported 
spontaneously without questioning, 3: strong vocal response or 
response accompanied by facial grimacing, arm withdrawal or 
tears). 
    SPSS 13.0 was used for the statistical analysis. The statistical 
measurement was shown as the number of patients or mean ± 
standard deviation. The gender ratio and physical status were 
compared by chi-square tests, and other factors of the patients’ 
characteristics were compared using one-way ANOVA test. For 
analysis of the results, comparing the incidence of coughing 
and the severity of pain after propofol administration was done 
using the chi-square test. Comparing the time of onset of cough 
was done with the one-way ANOVA test. P < 0.05 was defined as 
statistically significant. 119 www.ekja.org
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Results
    There were no differences of the characteristics amongst the 
3 groups (Table 1). None of the patients experienced hypoxia, 
apnea, muscle rigidity of the trunk or other side-effects after 
remifentanil administration.
    The incidence of coughing was significantly lower in Group 
R, which received graded escalation of remifentanil (6 patients, 
12%), and Group L, which received lidocaine administration 
(7 patients, 14%), than that in Group S, which received normal 
saline administration (17 patients, 34%) (Fig. 1, P < 0.05). 
However, there was no significant difference between Group 
R and Group L for the incidence of coughing. There were no 
significant differences amongst the 3 groups for the cough 
severity or the onset times of cough (26.9 ± 9.2 vs. 29.1 ± 8.6 vs. 
22.5 ± 7.6, respectively). There were no significant statistical 
differences among the three groups for the severity of the pain 
after propofol infusion (Group S had 23 cases with a pain score 
0 and 27 cases with a pain score 1, Group R had 22 cases and 27 
cases with a pain score 0 and 1 and Group L had 18 cases and 28 
cases with a pain score 0 and 1, respectively) (Table 2). 
Discussion 
    In this study, we concluded that the incidence of remifentanil-
induced coughing during anesthetic induction was reduced by 
graded escalation of the remifentanil concentration using a TCI 
pump, and this was as effective as pretreatment with lidocaine 1 
mg/kg (P < 0.05). 
    In the present study, when remifentanil’s effect site concen-
tration was set at 4.0 ng/ml, the incidence of coughing was 34%, 
which is slightly higher than that reported by Kim et al. [2,3] who 
set the effect site concentration at 4.0 ng/ml and 5.0 ng/ml and 
the incidence of coughing was 27.6% and 27.9%, respectively. 
The difference is believed to be caused by the different 
characteristics of the subjects of the two studies. Smokers were 
excluded in our study, but Kim et al. included them in their 
report. There have been reports showing that smoking reduced 
the incidence of fentanyl-induced coughing [9,10]. Kim et al. 
reported that the incidence of remifentanil induced coughing 
was lower in smokers than that in non  smokers [2]. Therefore, 
the higher incidence of coughing in our study is considered to 
be due to the exclusion of smokers. 
Table 1. The Patients’ Characteristics and the Remfentanil Dose 
Group S
 (n = 50)
 Group R
 (n = 50)
 Group L
 (n = 50)
Sex (M/F) 16/34   19/31  14/36 
ASA physical status (I/II) 35/15   39/11  39/11 
Age (yr)  43.4 ± 10.3  43.1 ± 10.9 44.0 ± 9.0
Height (cm) 164.0 ± 8.6 164.5 ± 8.9 162.4 ± 6.8
Weight (kg)  63.0 ± 10.9  63.7 ± 11.3  62.6 ± 10.4  
Remifentanil dose (μg)  63.5 ± 5.4  65.3 ± 6.1 62.6 ± 5.0
Values are the number of patients or mean ± SD. Group S: pretreated 
with saline and remifentanil infusion at an effect site concentration 
of 4 ng/ml, Group R: pretreated with saline and remifentanil infusion 
at an effect site concentration of 2 ng/ml at first and then this was 
reset to 4 ng/ml, Group L: pretreated with lidocaine and remifentanil 
infusion at an effect site concentration of 4 ng/ml. There was no dif-
ference between the groups. 
Table 2. Pain Score after Propofol Infusion and the Onset Time of 




0 1 2 3
Group S (n=50) 23 (46%) 27 (54%) 0 0 26.9 ± 9.2
Group R (n=50) 22 (44%) 27 (54%) 1 (2%) 0 29.1 ± 8.6
Group L (n=50) 22 (44%) 28 (56%) 4 (8%) 0 22.5 ± 7.6
Values are the number of patients. Group S: pretreated with saline 
and remifentanil infusion at an effect site concentration of 4 ng/ml, 
Group R: pretreated with saline and remifentanil infusion at an ef-
fect site concentration of 2 ng/ml at first and then this was reset to 4 
ng/ml, Group L: pretreated with lidocaine and remifentanil infusion 
at an effect site concentration of 4 ng/ml. Pain score 0: negative re-
sponse to question, 1: pain in response to questioning only without 
any behavioral signs, 2: pain in response to questioning and accom-
panied by behavioral signsor pain reported spontaneously without 
questioning, 3: strong vocal response or response accompanied by 
facial grimacing, arm withdrawal or tears. There was no difference 
in the pain score after propofol infusion and the onset time of cough 
after remifentanil infusion between the groups.
Fig. 1. The incidence and severity of cough after remifentanil infu-
sion. Values are the number of patients. Group S: pretreated with 
saline and remifentanil infusion at an effect site concentration of 4 
ng/ml, Group R: pretreated with saline and remifentanil infusion at 
an effect site concentration of 2 ng/ml at first and then this was reset 
to 4 ng/ml, Group L: pretreated with lidocaine and remifentanil in-
fusion at an effect site concentration of 4 ng/ml. *P < 0.05 compared 
with Group S. 120 www.ekja.org
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    The exact mechanism of opioid-induced coughing is not 
known, but some probable causes have been suggested. 
Opioids block the outflow of the central nervous system and 
activate the vagal nerve, which causes coughing and reflex 
bronchial constriction. The suppression of the fentanyl-induced 
cough reflex after the inhalation of bronchodilators (terbutaline 
and salbutamol) supports the theory of bronchial constriction 
[6,7,11]. Moreover, although fentanyl hardly causes the release 
of histamine, the histamines released from pulmonary mast-
cells have been reported to be the cause of fentanyl-induced 
coughing [12]. A different mechanism is that opioids constrict 
the bronchial smooth muscle and this causes remodeling of the 
bronchial wall. This stimulates the receptors, which trigger the 
cough reflex via the vagal afferent pathway [13].
    Intravenous infusion of lidocaine is known to suppress the 
cough reflex as well as all of the mechanically-induced and 
chemically-induced airway reflexes [14-16]. Pandey et al. 
[17] asserted that the minimum dose of lidocaine to suppress 
fentanyl-induced coughing is 0.5 mg/kg, but further increasing 
the amount does not decrease the incidence of fentanyl-
induced coughing. However, Lin et al. [8] argued that lidocaine 
2 mg/kg effectively suppresses fentanyl-induced coughing. 
In the present study, we tried to suppress the remifentanil-
induced coughing by pretreating the patient with lidocaine 1 
mg/kg. The coughing was reduced from 34% to 14%, which is 
similar to the results of Pandey et al. However, it is not possible 
to know if this was the optimal lidocaine dose for preventing 
remifentanil-induce coughing. Further study is required on the 
optimal lidocaine dose. 
  Lin et al. [9] reported that fentanyl-induced coughing can 
be reduced by solely decreasing the infusion rate of fentanyl 
without the pretreatment with other drugs. Bailey also reported 
that the cough reflex after the administration of opioids is partly 
related to the circulation time, which can be a clinical clue to 
determine the ‘vein-to-brain’ time and the cardiac output [18]. 
From a pharmacological perspective, the length of the drug 
infusion time can affect the peak plasma concentration. As 
the infusion time is prolonged, the peak plasma concentration 
is lowered. The threshold of remifentanil-induced coughing 
is more easily reached at a high peak plasma concentration. 
Therefore, prolonging the infusion time can decrease 
remifentanil-induced coughing. In this study, we used a TCI 
pump to have remifentanil reach the effect site concentration 
of 2.0 ng/ml. Then we increased the remifentanil in phases up 
to 4.0 ng/ml. As a result, the incidence of coughing was reduced 
from 34% to 12%. We can infer this occurred because Group R 
had a lower peak plasma concentration than that of Group S. 
    The incidence of pain caused by propofol for anesthetic 
induction varies from 28-90% [19]. Remifentanil and lidocaine 
are known to reduce pain [20]. In this study, we administered 
remifentanil at a concentration of 4 ng/ml and we pretreated 
the patients with lidocaine and normal saline. The incidence of 
propofol induced pain was around 54-64% with no significant 
differences amongst the three groups. To prevent propofol 
induced pain, remifentanil or lidocaine had no additive/
synergistic effect, and lidocaine had no significant effect. More 
studies on the dosage of the two drugs and their additive and 
synergistic effects are needed.
    In conclusion, graded escalation of the remifentanil 
concentration when performing anesthetic induction reduced 
the remifentanil induced coughing as effectively as lidocaine 1 
mg/kg pretreatment. So, it is believed that the graded escalation 
of the remifentanil concentration alone without pretreatment 
with any other drugs can effectively suppress the incidence of 
coughing. 
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